Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection (injection) from Hospira, Inc., a Pfizer Company with status Current. The shortage was first posted on 02/20/2018. Reported reason: Other
Shortage Details
- Status
- Current
- Company
- Hospira, Inc., a Pfizer Company
- Package NDC
- 0409-9045-01
- Dosage Form
- Injection
- Presentation
- Bupivacaine Hydrochloride And Epinephrine, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-9045-01)
- Initial Posting
- 02/20/2018
- Revised Date
Reason
Other